WAIn ForceRegulation
Medicines and Poisons Regulations 2016
Sch 4reportable poison has the meaning given in section 77(1);
Start here
Get a plain-English read of Sch 4
Turn the raw legal text into a practical explanation grounded in Medicines and Poisons Regulations 2016.
Schedule 4 reportable poison has the meaning given in section 77(1);
Note for this definition:
See also regulation 7A.
section means section of the Act;
structured administration and supply arrangement ***(SASA)*** means a document —
(a) that sets out the circumstances in which a health professional specified, or of a class specified, in the document may administer or supply a medicine specified in the document; and
(b) that is issued in accordance with regulation 33(1), 34(2) or 35(1).
(2) For the purposes of these regulations, the definitions and interpretation provisions in the current Poisons Standard apply to the interpretation of the current Poisons Standard.
(3) Unless the contrary intention appears, a reference in these regulations to a Schedule is a reference to a Schedule referred to in section 4(1).
[Regulation 3 amended: Gazette 13 Nov 2018 p. 4429; 15 Mar 2019 p. 787; 19 Nov 2019 p. 4051; SL 2023/3 r. 4 and 7; SL 2024/265 r. 4.]
##### 4. Needle and syringe programme prescribed
An approved needle and syringe programme is prescribed as a type of needle and syringe programme for the purposes of section 17(b).
##### 5. Fees
(1) For the purposes of section 38(2), the application fee and the licence fee for a licence are the fees set out in Schedule 1 Division 1 to these regulations for a licence of that type.
(2) For the purposes of section 38(2), the application fee and the permit fee for a permit are the fees set out in Schedule 1 Division 2 to these regulations for a permit of that type.
(3) For the purposes of a provision listed in Schedule 1 Division 3 to these regulations, the fee is the fee set out in that Division in respect of that provision.
## Part 2 — Substances as poisons
[Heading amended: SL 2024/265 r. 5.]
##### 6. Classification of substances as poisons included in Schedules (s. 4)
Each substance, other than an exempt substance or nicotine, described in an item in the Table is classified as a poison included in the Schedule specified in that item.
| **Item** | **Schedule** | **Description of substance** |
| 1. | Schedule 2 | A substance listed in the current Poisons Standard Schedule 2 |
| 2. | Schedule 3 | A substance listed in the current Poisons Standard Schedule 3 |
| 3. | Schedule 4 | A substance listed in the current Poisons Standard Schedule 4<br>SCAEVOLA SPINESCENS |
| 4. | Schedule 5 | A substance listed in the current Poisons Standard Schedule 5 |
| 5. | Schedule 6 | A substance listed in the current Poisons Standard Schedule 6 |
| 6. | Schedule 7 | A substance listed in the current Poisons Standard Schedule 7 |
| 7. | Schedule 8 | A substance listed in the current Poisons Standard Schedule 8 |
| 8. | Schedule 9 | A substance listed in the current Poisons Standard Schedule 9<br>A substance listed in Schedule 2 to these regulations |
[Regulation 6 amended: SL 2023/3 r. 7; SL 2024/218 r. 4.]
##### 6A. Classification of nicotine as poison (s. 4)
included in the Register has the meaning given in the *Therapeutic Goods Act 1989* (Commonwealth) section 3;
oromucosal administration means oromucosal use as defined in the current Poisons Standard section 6;
therapeutic use has the meaning given in the current Poisons Standard section 6;
transdermal administration means transdermal use as defined in the current Poisons Standard section 6.
(2) Each substance described in an item in the Table is classified as a poison included in the Schedule specified in that item.
| **Item** | **Schedule** | **Description of substance** |
| 1. | Schedule 4 | NICOTINE in preparations for human use **except**:<br> (a) in preparations for oromucosal or transdermal administration for human therapeutic use when included in the Register as an aid in withdrawal either from tobacco smoking or nicotine vaping; or<br> (b) in tobacco prepared and packed for smoking. |
| 2. | Schedule 7 | NICOTINE **except**:<br> (a) when included in Schedule 4; or<br> (b) in preparations for oromucosal or transdermal administration for human therapeutic use when included in the Register as an aid in withdrawal either from tobacco smoking or nicotine vaping; or<br> (c) in tobacco prepared and packed for smoking. |
[Regulation 6A inserted: SL 2024/218 r. 5.]
##### 7. Classification of substances as strictly controlled substances (s. 5)
Each substance listed in the current Poisons Standard Schedule 10 is classified as a strictly controlled substance.
[Regulation 7 amended: SL 2023/3 r. 7.]
##### 7A. Schedule 4 reportable poisons (s. 77(2))
For the purposes of the definition of ***Schedule 4 reportable poison*** in section 77(1), each Schedule 4 poison specified in Schedule 6 of these regulations is a drug of addiction.
[Regulation 7A inserted: SL 2024/265 r. 6.]
## Part 3 — Supply and use of strictly controlled substances
##### 8. Authorisation to supply or use strictly controlled substance
(1) The CEO may, for the purposes of section 18(1)(a)(ii) or (2)(a)(ii), authorise a person to supply or use a strictly controlled substance if the CEO is satisfied that —
(a) the supply or use of the substance is for educational or research purposes; and
(b) the supply or use of the substance will be conducted in a manner that protects the health, safety and welfare of the public.
(2) The authorisation —
##### 9. Authorisation to supply or use amygdalin
legally imported amygdalin means amygdalin that has been imported in accordance with permission granted under the *Customs (Prohibited Imports) Regulations 1956* (Commonwealth) regulation 5H and Schedule 8 item 12AA.
(2) For the purposes of section 18(2)(a)(i), a person is authorised to use legally imported amygdalin if the person uses the amygdalin on the direction of a medical practitioner.
## Part 4 — Prescriptions and prescribing
### Division 1 — Requirements for prescriptions
##### 10. Requirements for prescriptions generally
(1) For the purposes of paragraph (c) of the definition of ***prescription*** in section 7(1), a document must —
(a) include the following information —
(i) the name, address and telephone number of the prescriber;
(ii) the date on which the document is issued;
(iii) the name and address of the patient for whom the medicine is prescribed or, in the case of a medicine that is prescribed for veterinary use, the species of animal to be treated and the name and address of the person who has the care of the animal;
(iiia) if the document is for the supply of a medicine that is a Schedule 4 poison and is not for veterinary use — the date of birth of the patient (unless the supplier otherwise verifies the date of birth of the patient when the medicine is supplied);
(iv) if the document is for the supply of a medicine that is a Schedule 8 poison and is not for veterinary use — the date of birth of the patient;
(v) a description and the quantity, dose, strength and form of each medicine that is to be supplied;
(vi) precise directions for use of each medicine that is to be supplied;
(vii) if the document provides for the medicine to be supplied on more than one occasion — the maximum number of times it may be supplied;
(viii) if the document is for the supply of a medicine that is a Schedule 8 poison on more than one occasion — the intervals at which it may be supplied;
and
(b) be issued by a prescriber in a form described in regulation 11(1).
(2) A prescription must not be for the supply of both a medicine that is a Schedule 4 poison and a medicine that is a Schedule 8 poison.
(3) A prescription that is issued by a veterinarian must include the words “For veterinary use only” or “For animal treatment only”.
(4) However, the requirements in this regulation do not apply in respect of a document if the document —
(a) is issued for a purpose set out in regulations 12, 13 or 14; and
(b) complies with the requirements in the relevant regulation for a document issued for that purpose.
[Regulation 10 amended: SL 2022/93 r. 5; SL 2024/265 r. 7.]
##### 11. Form of prescription
(1) For the purposes of regulation 10(1)(b), a document can be in any of the following forms —
(a) an electronic document issued by the prescriber by means of an approved electronic prescribing system;
(b) a printed form that is —
(i) generated by means of a computer system that satisfies the requirements set out in subregulation (2); and
(ii) signed in ink by the prescriber;
(c) a document —
(i) with the details referred to in regulation 10(1)(a)(ii) to (viii) written in ink by the prescriber; and
(ii) signed in ink by the prescriber.
(2) For the purposes of subregulation (1)(b)(i), a computer system must be designed so that —
(a) only a prescriber may generate the form; and
(b) the form when printed indicates the total number of items to be supplied, or is scored, hatched or otherwise marked to prevent any other item being added to the form after it is generated; and
(c) a prescriber must determine, on each occasion, the specific directions for use of each medicine that is to be supplied; and
(d) the form contains a number which uniquely identifies it; and
(e) particulars of the form are included in the clinical or prescription record of the person or animal to be supplied with the items identified in the form; and
(f) the clinical or prescription record of the person or animal to be supplied with the items identified in the form is —
(i) in the case of an item that is a medicine that is a Schedule 4 poison — preserved for at least 2 years from the date on which the form is generated; and
(ii) in the case of an item that is a medicine that is a Schedule 8 poison — preserved for at least 5 years from the date on which the form is generated.
[Regulation 11 amended: SL 2024/265 r. 8.]
##### 12. Medication chart for patient in hospital
For the purposes of paragraph (c) of the definition of ***prescription*** in section 7(1), a document issued for the purpose of supplying a medicine that is a Schedule 4 or 8 poison for the use by a patient in a hospital can only be in the form of a medication chart if the chart meets the following requirements —
(b) for a medication chart completed in hard copy form — the prescriber has, in ink, signed and dated each entry in the chart about the medicine;
(c) for a medication chart completed in electronic form — the prescriber has completed the chart using an approved electronic prescribing system.
[Regulation 12 inserted: SL 2024/265 r. 9.]
##### 13. Medication chart for patient discharged from hospital
For the purposes of paragraph (c) of the definition of ***prescription*** in section 7(1), a document issued for the purpose of supplying a medicine that is a Schedule 4 or 8 poison when a patient is discharged from hospital can only be in the form of a medication chart if the chart meets the following requirements —
(b) for a medication chart completed in hard copy form — the prescriber has, in ink, written, signed and dated an authorisation for the medicine to be dispensed when the patient is discharged;
(c) for a medication chart completed in electronic form —
(i) the prescriber has electronically recorded on the chart an authorisation for the medicine to be dispensed when the patient is discharged; and
(ii) the prescriber has completed the chart using an approved electronic prescribing system.
[Regulation 13 inserted: SL 2024/265 r. 9.]
##### 14. Chart for person in residential care
(1) For the purposes of paragraph (c) of the definition of ***prescription*** in section 7(1), a document issued for the purpose of supplying a medicine that is a Schedule 4 poison for the use of a person who is a care recipient in a residential care facility can only be in the form of a residential care chart if the chart meets the following requirements —
(a) for a residential care chart completed in hard copy form —
(i) all the details required by the chart about the person and the medicine have been completed in ink; and
(ii) each entry in the chart about the medicine has been completed in ink; and
(iii) the prescriber has, in ink, signed and dated each entry in the chart about the medicine;
(b) for a residential care chart completed in electronic form —
(i) all the details required by the chart about the person and the medicine have been completed; and
(ii) the prescriber has completed the chart using an approved electronic prescribing system.
(2) For the purposes of paragraph (c) of the definition of ***prescription*** in section 7(1), a document issued for the purpose of supplying a medicine that is a Schedule 8 poison for the use of a person who is a care recipient in a residential care facility can only be in the form of a residential care chart if the chart meets the following requirements —
(b) the prescriber has completed the chart using an approved electronic prescribing system.
[Regulation 14 inserted: SL 2024/265 r. 9.]
### Division 2 — Directions by prescriber
##### 15. Direction by prescriber to administer medicine that is Schedule 4 or 8 poison
(1) A prescriber may give a direction for an authorised health professional to administer a medicine that is a Schedule 4 or 8 poison to a particular person (the patient).
(a) by entering in the clinical record of the patient any details referred to in regulation 10(1)(a)(i) to (v) that are not already included in the clinical record and signing the entry; or
(b) by entering all the details about the patient and the medicine required by the medication chart or the residential care chart for the patient and signing the entry; or
(c) to an authorised health professional orally or by telephone or other electronic means.
(3) If a prescriber gives a direction to an authorised health professional in a form described in subregulation (2)(c), the prescriber must, within 24 hours of giving the direction —
(a) enter all the details about the patient and the medicine required by the medication chart or the residential care chart for the patient and sign the entry; or
(b) enter in the clinical record of the patient any details referred to in regulation 10(1)(a)(i) to (v) that are not already included in the clinical record and sign the entry.
##### 16. Direction by prescriber to administer medicine that is Schedule 4 or 8 poison to animal
(1) A prescriber may give a direction for an authorised health professional to administer a medicine that is a Schedule 4 or 8 poison to a particular animal (the animal).
(a) by entering in the clinical record of the animal any details referred to in regulation 10(1)(a)(i) to (v) that are not already included in the clinical record and signing the entry; or
(b) to an authorised health professional orally or by telephone or other electronic means.
(3) If a prescriber gives a direction to an authorised health professional in a form described in subregulation (2)(b), the prescriber must, within 24 hours of giving the direction enter in the clinical record of the animal any details referred to in regulation 10(1)(a)(i) to (v) that are not already included in the clinical record and sign the entry.
##### 16A. Direction by prescriber to supply medicine that is Schedule 2, 3 or 4 poison
(1) A prescriber may give a direction for an authorised health professional to supply a medicine that is a Schedule 2, 3 or 4 poison to a particular person (the patient).
(a) by entering in the clinical record of the patient any details referred to in regulation 10(1)(a)(i) to (vii) that are not already included in the clinical record and signing the entry; or
(b) to an authorised health professional orally or by telephone or other electronic means.
(3) If a prescriber gives a direction to an authorised health professional in a form described in subregulation (2)(b), the prescriber must, within 24 hours of giving the direction, enter in the clinical record of the patient any details referred to in regulation 10(1)(a)(i) to (vii) that are not already included in the clinical record and sign the entry.
[Regulation 16A inserted: Gazette 15 Mar 2019 p. 787.]
##### 17. Direction by prescriber to supply medicine that is Schedule 4 or 8 poison in emergency
(1) A prescriber may give a direction for a pharmacist to supply a medicine that is a Schedule 4 or 8 poison to a person.
(2) The direction —
(a) may be given orally or by telephone or other electronic means; and
(b) may only be given in an emergency.
(3) If a direction is given under subregulation (1), the prescriber must —
(a) prepare a document for the supply of the medicine in accordance with the requirements in regulation 10(1); and
(b) mark the document to show that it is a confirmation of a direction given orally or by telephone or other electronic means; and
(c) send the document within 24 hours to the pharmacist.
(4) A pharmacist who supplies a medicine that is a Schedule 8 poison on a direction given under subregulation (1) must notify the CEO if the pharmacist does not receive the document for the supply of the medicine required under subregulation (3) within 5 working days of the supply of the medicine.
### Division 3 — Electronic prescribing systems
##### 18. Terms used
(1) In this Division —
access code, of a person, means a password or other means by which the person gains access to an electronic system;
personal information has the meaning given in the *Freedom of Information Act 1992* in the Glossary clause 1;
system identifier, of a person, means the code by which the identity of the person is recorded by an electronic system.
(2) For the purposes of this Division, an entry is made in an electronic system if —
(a) a prescription is issued, amended or cancelled using the system; or
(b) the system is used for the purpose of dispensing a medicine that is a Schedule 4 or 8 poison; or
(c) information is otherwise entered into or retrieved from the system in relation to —
(i) issuing, amending or cancelling a prescription using the system; or
(ii) the use of the system for the purpose of dispensing a medicine that is a Schedule 4 or 8 poison.
##### 19. Approval of electronic system
(1) A person may apply to the CEO for approval of an electronic system to be used for the purpose of issuing prescriptions for medicines that are Schedule 4 or 8 poisons and for the dispensing of those medicines.
(2) An application must be in an approved form.
(4) The CEO may approve an electronic system to be used for issuing prescriptions for medicines that are Schedule 4 or 8 poisons and for the purpose of dispensing those medicines if satisfied that the system —
(a) is sufficiently secure; and
(b) is designed so that, to the extent practicable, for a particular medicine —
(i) only a prescriber can use the system to issue a prescription for the medicine; and
(ii) only a pharmacist, or an assistant under the direct personal supervision of a pharmacist, can use the system for the purpose of dispensing the medicine;
and
(c) complies substantially with the criteria in regulation 20; and
(d) complies with any other criteria the CEO thinks relevant.
(5) Before being satisfied that an electronic system is sufficiently secure, the CEO must be satisfied that, to the extent practicable —
(a) personal information included in the system is protected; and
(b) access to and use of the system is controlled by appropriate procedures; and
(c) only persons permitted to have access to the system according to those procedures can have access to the system; and
(d) the system records in a way that cannot be amended or erased every occurrence of —
(i) a prescription being issued or amended using the system; and
(ii) the use of the system for the purpose of dispensing a medicine.
(6) Subregulation (5) does not limit the matters that the CEO may take into account for the purposes of subregulation (4)(a).
##### 20. Criteria for electronic system
For the purposes of regulation 19(4)(c), the criteria for an electronic system are that the system must be designed so that —
(a) only an individual can be given an access code; and
(b) the system records in a way that cannot be amended or erased —
(i) each person who is given an access code; and
(ii) the date that the access code is given; and
(iii) if the access code is cancelled — the date that it is cancelled;
and
(c) each entry made in the system is given a unique sequential number; and
(d) for each entry made in the system, the system records in a way that cannot be amended or erased —
(i) the time and date the entry is made; and
(ii) the system identifier of the person whose access code is used to make the entry;
and
(e) the system requires that persons with access to the system change their access code in accordance with standard industry practice; and
(f) appropriate backup arrangements are in place; and
(g) the system records the details of each person who is an administrator of the system and retains those details for 7 years after the person ceases to be an administrator; and
(h) the system can generate appropriate reports from its records including reports of —
(i) persons who have been given an access code and have access to the system during a particular period; and
(ii) entries made in the system during a particular period; and
(iii) entries made in the system sorted according to medicine type, strength or dose or according to patient; and
(iv) corrections to entries made in the system during a particular period;
and
(i) the records of the system can be produced on demand.
##### 21. System to have administrator
An approval given under regulation 19(4) has no effect during any period for which there is no individual designated by the CEO as the administrator of the electronic system.
##### 22. Offences
inappropriate use, in relation to an approved electronic prescribing system, includes using the system in a way that is not in accordance with the procedures that control access to and use of the system;
unauthorised person, in relation to an approved electronic prescribing system, means a person who is not permitted to access the system in accordance with the procedures that control access to and use of the system.
(2) A person must not make inappropriate use of an approved electronic prescribing system.
(3) A person who has an access code for an approved electronic prescribing system must not —
(a) reveal the person’s access code to another person; or
(b) do anything to allow an unauthorised person to gain access to the system.
(4) An administrator of an approved electronic prescribing system must, to the extent practicable, ensure that —
(a) only one access code is given to each person who is permitted to have access to the system; and
(b) each person who is responsible to the administrator for the operation and control of the system does not make inappropriate use of the system.
### Division 4 — Real‑time prescription monitoring system
[Heading inserted: SL 2024/265 r. 10.]
##### 22A. Requirement to register with real‑time prescription monitoring system
real‑time prescription monitoring system means an electronic system —
(a) operated by or on behalf of the Department; and
(b) used to monitor the dispensing and prescribing of relevant medicines;
relevant health professional means a dentist, endorsed midwife, endorsed podiatrist, medical practitioner, nurse practitioner or pharmacist;
relevant medicine means a medicine that is a Schedule 4 reportable poison or a Schedule 8 poison.
(2) This regulation applies to a relevant health professional who dispenses or prescribes a relevant medicine to a patient.
(3) Before dispensing or prescribing the medicine, the health professional must register with a real‑time prescription monitoring system.
[Regulation 22A inserted: SL 2024/265 r. 10.]
## Part 5 — Supplying medicine that is Schedule 4 or 8 poison
##### 23. Dispensing medicine that is Schedule 4 or 8 poison
(1) A pharmacist who dispenses a medicine that is a Schedule 4 or 8 poison must —
(a) be satisfied that —
(i) the prescription is completed and issued in accordance with the requirements in Part 4; and
(ii) the class of health professional of which the person issuing the prescription is a member, is a class that is authorised to prescribe the medicine;
and
(b) comply with the directions on the prescription; and
(c) on each occasion on which the medicine is dispensed —
(i) if an approved electronic prescribing system is used for the purpose of dispensing the medicine — provide the information referred to in subregulation (2) by means of the approved electronic prescribing system; or
(ii) in all other cases — mark on the prescription the information referred to in subregulation (2);
and
(d) record the dispensing of the medicine in accordance with Part 12; and
(e) in the case of a prescription for a medicine that is a Schedule 8 poison not issued using an approved electronic prescribing system —
(i) retain the prescription; or
(ii) transfer the prescription to another pharmacist.
(2) The information to be provided or marked on a prescription is the following —
(a) the prescription reference number;
(b) the amount of the medicine that is dispensed;
(c) the date on which the medicine is dispensed;
(d) the name and address of the pharmacy where the medicine is dispensed.
(3) A pharmacist must not dispense a medicine that is a Schedule 4 or 8 poison if —
(a) the prescription —
(i) in the case of a prescription for a medicine that is a Schedule 4 poison — is more than 12 months old; or
(ii) in the case of a prescription for a medicine that is a Schedule 8 poison — is more than 6 months old;
or
(b) the prescription is illegible or appears to have been altered by a person other than the prescriber who issued it; or
(c) the prescription is cancelled in accordance with regulation 26.
[Regulation 23 amended: SL 2024/265 r. 11.]
##### 24. Repeat dispensing of medicine that is Schedule 4 or 8 poison
(1) A pharmacist who dispenses a medicine that is a Schedule 4 poison to a person must, if the prescription is for the supply of the medicine on more than one occasion, prepare and provide to the person —
(a) a duplicate of the prescription; and
(b) a form that specifies the remaining number of occasions on which the medicine is authorised to be supplied in accordance with the prescription (a repeat form).
(2) A pharmacist who dispenses a medicine that is a Schedule 8 poison must, if the prescription is for the supply of the medicine on more than one occasion, prepare and retain —
(a) a duplicate of the prescription; and
(b) a form that specifies the remaining number of occasions on which the medicine is authorised to be supplied in accordance with the prescription (a repeat form).
(3) A duplicate prescription with a repeat form that authorises the supply of a medicine on at least one occasion is taken to be a prescription for the purpose of dispensing the medicine.
(4) This regulation does not apply to a prescription for the supply of a medicine that is a Schedule 4 or 8 poison if that prescription is issued using an approved electronic prescribing system.
[Regulation 24 amended: SL 2024/265 r. 12.]
##### 25. Pharmacist to confirm details of prescription for medicine that is Schedule 8 poison
(1) A pharmacist who is presented with a prescription for the supply of a medicine that is a Schedule 8 poison must take reasonable steps to confirm —
(a) the authenticity of the prescription; and
(b) the identity of the person who issued the prescription; and
(c) the bona fides of the person wishing to have the medicine supplied in accordance with the prescription.
(2) If, despite taking reasonable steps, a pharmacist is unable to confirm the matters referred to in subregulation (1)(a) to (c) in respect of a prescription, the pharmacist may supply a quantity of the medicine required to provide treatment for 2 days in accordance with the directions for use for the medicine included in the prescription.
(3) This regulation does not apply in respect of a prescription issued using an approved electronic prescribing system.
##### 26. Cancelling prescription or document
(1) A pharmacist must cancel a prescription for a medicine that is a Schedule 4 or 8 poison in the following circumstances —
(a) the medicine has been dispensed on one occasion and the prescription does not clearly indicate the maximum number of occasions on which the medicine is to be dispensed;
(b) the medicine is a Schedule 8 poison that has been dispensed on one occasion and the prescription does not clearly indicate the intervals at which the medicine is to be dispensed;
(c) the medicine has already been dispensed on the maximum number of occasions specified in the prescription.
(2) A pharmacist must cancel a document that is presented as a prescription for the supply of a medicine that is a Schedule 4 or 8 poison if the pharmacist is satisfied that the document —
(a) is not completed or issued in accordance with the requirements in Part 4; or
(b) was not issued by a person who was authorised to prescribe the medicine; or
(c) is false in a material particular.
(3) A prescription or document must be cancelled —
(a) in the case of a prescription or document that is issued using an approved electronic prescribing system — by the means provided by the approved electronic prescribing system; or
(b) in any other case — by marking the word “cancelled” across the prescription or document.
(4) If a pharmacist cancels a document under subregulation (2)(c), the pharmacist must —
(a) inform the CEO that the document has been cancelled; and
(b) advise the CEO of the reasons for cancelling the document.
##### 27. Dispensing medicine that is Schedule 8 poison to drug dependent or oversupplied person
A pharmacist may dispense a medicine that is a Schedule 8 poison, other than an opioid pharmacotherapy, to a drug dependent person or an oversupplied person.
##### 28. Dispensing opioid pharmacotherapy for drug dependent person or oversupplied person
(1) The CEO may authorise a pharmacy to dispense opioid pharmacotherapies to drug dependent persons or oversupplied persons.
(2) The authorisation —
(3) A pharmacist may, at a pharmacy, dispense an opioid pharmacotherapy to a drug dependent person or an oversupplied person if —
(a) an authorisation has been given under subregulation (1) in respect of the pharmacy; and
(b) the pharmacist does so in accordance with the authorisation.
##### 29. Supplying medicine that is Schedule 4 poison in emergency
(1) A pharmacist may supply a medicine that is a Schedule 4 poison to a person if the pharmacist is satisfied on reasonable grounds that —
(a) the person is under regular treatment with the medicine; and
(b) it is not practical for the person to obtain a prescription in sufficient time to allow for treatment with the medicine to continue uninterrupted; and
(c) interruption of treatment with the medicine is likely to cause harm to the person.
(2) The maximum quantity of a medicine that may be supplied under subregulation (1) is the quantity required for 3 days of the regular treatment of the person.
##### 30. Supplying medicine that is Schedule 4 poison for emergency veterinary use
(1) A pharmacist may supply a medicine that is a Schedule 4 poison to a person if the pharmacist is satisfied on reasonable grounds that —
(a) the person requires the medicine for treatment of an animal which is under regular treatment with the medicine; and
(b) it is not practical for the person to obtain a prescription in sufficient time to allow for treatment with the medicine to continue uninterrupted; and
(c) interruption of treatment with the medicine is likely to cause harm to the animal.
(2) The maximum quantity of a medicine that may be supplied under subregulation (1) is the quantity required for 3 days of the regular treatment of the animal.
##### 31. Supplying medicine that is Schedule 4 or 8 poison on direction of prescriber
A pharmacist may supply a medicine that is a Schedule 4 or 8 poison on a direction given under regulation 17(1).
##### 32. Supplying medicine that is Schedule 4 or 8 poison to authorised health professional
A pharmacist must not supply a medicine that is a Schedule 4 or 8 poison to an authorised health professional unless —
(a) the medicine is supplied in accordance with a prescription; or
(b) the pharmacist —
(i) is satisfied that the supply is for the purpose of administration or supply of the medicine by the health professional in the lawful practice of their profession; and
(ii) obtains from the health professional a written request specifying the quantity, dose, strength and form of the medicine that is to be supplied.
## Part 6 — Structured administration and supply arrangement
##### 33. SASA issued by CEO
(1) The CEO may issue a SASA that applies throughout the State.
(2) A SASA issued by the CEO must —
(i) the class of health professional to which it applies;
(ii) a description of each medicine to which it applies;
(iii) the circumstances in which the medicine may be administered or supplied by a health professional.
(3) For the purposes of subregulation (2)(b)(i), a class of health professional may be identified by reference to any of the following —
(a) a qualification held by the health professional;
(b) the employment circumstances of the health professional;
(c) any other criteria the CEO thinks relevant.
(4) A SASA issued by the CEO must be published on the Department’s website.
[Regulation 33 amended: Gazette 13 Nov 2018 p. 4429.]
##### 34. SASA issued for health organisation
clinical governance committee means a committee constituted by at least 3 members including a medical practitioner, a registered nurse and a pharmacist.
(2) The chief executive officer of a health organisation may issue a SASA that applies in respect of the practice of authorised health professionals of a specified class who —
(a) are employed in the organisation; or
(b) provide services to the organisation under a contract for services.
(3) Each SASA issued by the chief executive officer of a health organisation must apply to only one medicine.
(4) A SASA issued by the chief executive officer of a health organisation must —
(i) the class of authorised health professional to which it applies;
(ii) a description of the medicine to which it applies;
(iii) the circumstances in which the medicine may be administered or supplied by an authorised health professional;
and
(c) be signed by the most senior medical practitioner employed in the organisation; and
(d) be approved by a clinical governance committee established by the chief executive officer of the organisation; and
(e) be made available to each health professional to whom it applies.
(5) For the purposes of subregulation (4)(b)(iii), the circumstances in which a medicine may be administered or supplied can only be circumstances relating to the acute care of a patient of the organisation or the implementation of a public health programme conducted by the organisation.
(6) A SASA issued by the chief executive officer of a health organisation —
(a) expires at the end of the period of 2 years beginning on the day it is issued unless earlier withdrawn; and
(b) cannot be reissued unless a review of the SASA has been carried out by the most senior medical practitioner employed in the organisation.
(7) The chief executive officer of a health organisation must, as soon as reasonably practicable after issuing a SASA in respect of the organisation, provide a copy of the SASA to the CEO.
(8) The chief executive officer of a health organisation must withdraw a SASA issued in respect of the organisation on the written direction of the CEO.
##### 35. SASA issued by medical practitioner
(1) A medical practitioner may issue a SASA that applies in respect of the practice of a specified authorised health professional employed by the medical practitioner.
(2) A SASA issued by a medical practitioner must —
(i) the name of the authorised health professional employed by the medical practitioner to which it applies;
(ii) a description of each medicine to which it applies;
(iii) the circumstances in which the medicine may be administered or supplied by the authorised health professional;
and
(c) be signed by the medical practitioner.
(3) For the purposes of subregulation (2)(b)(iii), the circumstances in which a medicine may be administered or supplied can only be circumstances relating to the acute care of a patient of the medical practitioner or the implementation of a public health programme in which the medical practitioner is participating.
(4) A SASA issued by a medical practitioner —
(a) expires at the end of the period of 2 years beginning on the day it is issued unless earlier withdrawn; and
(b) cannot be reissued unless a review of the SASA has been carried out by the medical practitioner.
(5) A medical practitioner who issues a SASA must make it available to the CEO on request.
(6) A medical practitioner must withdraw a SASA issued by the medical practitioner on the written direction of the CEO.
Penalty for this subregulation: a fine of $2 000.
##### 36. Requirement for SASA applying to medicine that is Schedule 8 poison
A SASA that relates to the administration or supply of a medicine that is a Schedule 8 poison must not include provisions that are inconsistent with Part 11.
## Part 7 — Authorisation of health professionals
##### 37. Terms used
Aboriginal and Torres Strait Islander health practitioner means a person registered under the *Health Practitioner Regulation National Law (Western Australia)* whose name is entered on the Register of Aboriginal and Torres Strait Islander Health Practitioners kept under that Law;
Aboriginal and Torres Strait Islander health worker means a person employed —
(a) by an Aboriginal Health Service to provide health care to Aboriginal or Torres Strait Islander people; or
(b) to provide a public health service to Aboriginal or Torres Strait Islander people;
Aboriginal Health Service means a health service that is a member of the Aboriginal Health Council of Western Australia (ACN 114 220 478);
anaesthetic technician means a person employed in a hospital to assist an anaesthetist in the hospital;
dental hygienist means a person registered under the *Health Practitioner Regulation National Law (Western Australia)* whose name is entered on the Dental Hygienist Division of the Register of Dental Practitioners kept under that Law;
dental therapist means a person registered under the *Health Practitioner Regulation National Law (Western Australia)* whose name is entered on the Dental Therapist Division of the Register of Dental Practitioners kept under that Law;
domestic commercial vessel has the meaning given in the Marine Safety (Domestic Commercial Vessel) National Law section 6 as set out in the *Marine Safety (Domestic Commercial Vessel) National Law Act 2012* (Commonwealth) Schedule 1;
endorsed optometrist means an optometrist whose registration is endorsed under the *Health Practitioner Regulation National Law (Western Australia)* section 94;
enrolled nurse means a person registered under the *Health Practitioner Regulation National Law (Western Australia)* in the nursing profession whose name is entered on Division 2 of the Register of Nurses kept under that Law as an enrolled nurse;
first aid provider (vessel) means a person on a vessel —
(a) whose duties include the provision of acute care for persons or animals who suffer a medical or veterinary condition on the vessel; and
(b) who is authorised by the captain of the vessel to obtain medicines for use on the vessel;
foreign vessel has the meaning given in the *Navigation Act 2012* (Commonwealth) section 14;
health organisation means any of the following —
(a) a public hospital;
(b) a private hospital;
(c) an organisation that is the holder of a health service permit;
health service permit means a permit of a type referred to in item 1, 2 or 3 of the Table to regulation 79(2);
medic —
(a) means a person who provides emergency health services, including ambulance services, in a location other than a hospital, and who is covered by one or more of the following —
(i) the person is employed by a medical practitioner to provide the services;
(ii) the person is employed, or engaged under a contract for services, by a health organisation to provide the services;
(iii) the person is under the supervision of a health organisation in respect of the provision of the services;
but
(b) does not include a paramedic;
midwife means a person registered under the *Health Practitioner Regulation National Law (Western Australia)* in the midwifery profession;
optometrist means a person registered under the *Health Practitioner Regulation National Law (Western Australia)* in the optometry profession;
oral health therapist means a person registered under the *Health Practitioner Regulation National Law (Western Australia)* whose name is entered on the Oral Health Therapist Division of the Register of Dental Practitioners kept under that Law;
paramedic means a person registered under the *Health Practitioner Regulation National Law (Western Australia)* in the paramedicine profession;
PBS means the document “Schedule of Pharmaceutical Benefits” published from time to time, for the purposes of the *National Health Act 1953* (Commonwealth), by the Department of State of the Commonwealth that is administered by the Commonwealth Minister administering that Act;
PBS medicine means a medicine that —
(a) is listed in any of the following Schedules of the PBS —
(i) General Pharmaceutical Benefits;
(ii) Palliative Care;
but
(b) is not listed in any of the following Schedules of the PBS —
(i) Highly Specialised Drugs Program (Private Hospital);
(ii) Highly Specialised Drugs Program (Public Hospital);
(iii) Highly Specialised Drugs Program (Community Access);
racing yacht means a yacht participating in a race departing from the State;
registered nurse means a person registered under the *Health Practitioner Regulation National Law (Western Australia)* in the nursing profession whose name is entered on Division 1 of the Register of Nurses kept under that Law as a registered nurse;
regulated Australian vessel has the meaning given in the *Navigation Act 2012* (Commonwealth ) section 15;
remote clinic means a medical clinic, nursing post or similar facility —
(a) operated by a health service that satisfies the conditions specified in the *National Health (Remote Area Aboriginal Health Services Program) Special Arrangement 2017* (Commonwealth) section 9(2); or
(b) approved by the CEO under regulation 39A;
supply does not include dispense;
vessel means each of the following —
(a) a domestic commercial vessel;
(b) a foreign vessel;
(c) a racing yacht;
(d) a regulated Australian vessel;
veterinary nurse has the meaning given in the *Veterinary Practice Act 2021* section 3;
VPB‑authorised person means a person authorised under the *Veterinary Practice Regulations 2022* regulation 14(1) to carry out the act of veterinary medicine specified in Schedule 6 item 12 of those regulations.
[Regulation 37 amended: Gazette 13 Nov 2018 p. 4429-30; 15 Mar 2019 p. 787-8; SL 2022/93 r. 4; SL 2024/265 r. 13; SL 2025/212 r. 4.]
##### 38. Classes of persons prescribed as health professionals
The following classes of persons are prescribed for the purposes of the definition of ***health professional*** in section 3 —
(a) Aboriginal and Torres Strait Islander health workers;
(b) anaesthetic technicians;
(c) first aid providers (vessel);
(d) medics;
(e) veterinary nurses;
(f) VPB‑authorised persons.
[Regulation 38 amended: Gazette 13 Nov 2018 p. 4430; SL 2025/212 r. 5.]
##### 39. Veterinary medicine not for human use
Nothing in this Part authorises the administration to a human or supply for human use of a poison which is prepared for veterinary use.
##### 39A. Approval of remote clinic
ASGS means the document “Australian Statistical Geography Standard (ASGS): Volume 5 ‑ Remoteness Structure, July 2016” published by the Australian Bureau of Statistics.
(2) The CEO may approve a medical clinic, nursing post or similar facility as a remote clinic if it is in an area of the State classified as Remote Australia or Very Remote Australia under the ASGS.
(3) The approval —
[Regulation 39A inserted: Gazette 15 Mar 2019 p. 788.]
### Division 2 — Authorisation of Aboriginal and Torres Strait Islander health professionals
##### 40. Classes of Aboriginal and Torres Strait Islander health professional prescribed for s. 25(1)(a)
(a) Aboriginal and Torres Strait Islander health practitioner;
(b) Aboriginal and Torres Strait Islander health worker.
##### 41. Authorisation of Aboriginal and Torres Strait Islander health practitioners
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that an Aboriginal and Torres Strait Islander health practitioner, acting in the lawful practice of their profession, may supply.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 poison is a medicine that an Aboriginal and Torres Strait Islander health practitioner, acting in the lawful practice of their profession, may —
(3) The supply by an Aboriginal and Torres Strait Islander health practitioner of a medicine that is a Schedule 2, 3 or 4 poison is subject to the condition that the supply is —
(a) in the circumstances described in subregulation (3A); or
(b) in the circumstances identified in a SASA that applies to the Aboriginal and Torres Strait Islander health practitioner in respect of the medicine.
(3A) For the purposes of subregulation (3)(a), the circumstances are as follows —
(c) when the supply occurs there is no pharmacy within 25 km of the place of supply that is open and accessible by the person to whom the medicine is supplied;
(d) the supply is not for the purposes of acute care or treatment relating to the implementation of a public health programme;
(e) the person to whom the medicine is supplied has consulted with a medical practitioner, in the period of 6 months before the day on which the supply occurs, about the medical condition to which the supply relates;
(f) the supply is on a direction given under regulation 16A(1) in respect of that particular supply;
(g) the Aboriginal and Torres Strait Islander health practitioner has completed a course of training approved by the CEO for the purposes of this subregulation.
(4) The administration by an Aboriginal and Torres Strait Islander health practitioner of a medicine that is a Schedule 4 poison is subject to the condition that the administration —
(b) is in the circumstances identified in a SASA that applies to the Aboriginal and Torres Strait Islander health practitioner in respect of the medicine.
(5) The possession by an Aboriginal and Torres Strait Islander health practitioner of a medicine that is a Schedule 4 poison is subject to the condition that the possession is for the purpose of administering or supplying the medicine in accordance with this regulation.
[Regulation 41 amended: Gazette 15 Mar 2019 p. 788-9.]
##### 42. Authorisation of **Aboriginal and Torres Strait Islander health workers**
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that an Aboriginal and Torres Strait Islander health worker, acting in the lawful practice of their profession, may supply.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 poison is a medicine that an Aboriginal and Torres Strait Islander health worker, acting in the lawful practice of their profession, may —
(3) The supply by an Aboriginal and Torres Strait Islander health worker of a medicine that is a Schedule 2, 3 or 4 poison is subject to the condition that the supply is —
(a) in the circumstances described in subregulation (3A); or
(b) in the circumstances identified in a SASA that applies to the Aboriginal and Torres Strait Islander health worker in respect of the medicine.
(3A) For the purposes of subregulation (3)(a), the circumstances are as follows —
(c) when the supply occurs there is no pharmacy within 25 km of the place of supply that is open and accessible by the person to whom the medicine is supplied;
(d) the supply is not for the purposes of acute care or treatment relating to the implementation of a public health programme;
(e) the person to whom the medicine is supplied has consulted with a medical practitioner, in the period of 6 months before the day on which the supply occurs, about the medical condition to which the supply relates;
(f) the supply is on a direction given under regulation 16A(1) in respect of that particular supply;
(g) the Aboriginal and Torres Strait Islander health worker has completed a course of training approved by the CEO for the purposes of this subregulation.
(4) The administration by an Aboriginal and Torres Strait Islander health worker of a medicine that is a Schedule 4 poison is subject to the condition that the administration —
(b) is in the circumstances identified in a SASA that applies to the Aboriginal and Torres Strait Islander health worker in respect of the medicine.
(5) The possession by an Aboriginal and Torres Strait Islander health worker of a medicine that is a Schedule 4 poison is subject to the condition that the possession is for the purpose of administering or supplying the medicine in accordance with this regulation.
[Regulation 42 amended: Gazette 15 Mar 2019 p. 789-90.]
### Division 3 — Authorisation of anaesthetic technicians
##### 43. Anaesthetic technician prescribed for s. 25(1)(a)
Anaesthetic technician is prescribed as a class of health professional for the purposes of section 25(1)(a).
##### 44. Authorisation of anaesthetic technicians
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 or 8 poison is a medicine that an anaesthetic technician, acting in the lawful practice of their profession, may —
(2) The administration by an anaesthetic technician of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the administration —
(a) is on a direction given by a medical practitioner under regulation 15(1); or
(b) is in the circumstances identified in a SASA that applies to the anaesthetic technician in respect of the medicine.
(3) The possession by an anaesthetic technician of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the possession is for the purpose of —
(a) administering the medicine in accordance with this regulation; or
(b) assisting an anaesthetist in a hospital.
### Division 4 — Authorisation of dental professionals
##### 45. Classes of dental professional prescribed for s. 25(1)(a)
(a) dentist;
(b) dental hygienist;
(c) dental therapist;
(d) oral health therapist.
##### 46. Authorisation of dentists
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that a dentist, acting in the lawful practice of their profession, may supply.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 or 8 poison is a medicine that a dentist, acting in the lawful practice of their profession, may —
(3) The prescription or supply by a dentist of a medicine that is a Schedule 8 poison is subject to Part 11.
##### 47. Authorisation of other dental staff
dental worker means each of the following —
(a) a dental hygienist;
(b) a dental therapist;
(c) an oral health therapist.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that a dental worker, acting in the lawful practice of their profession, may supply.
(3) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 or 8 poison is a medicine that a dental worker, acting in the lawful practice of their profession, may —
(4) The supply by a dental worker of a medicine that is a Schedule 2 or 3 poison is subject to the condition that the supply is in the circumstances identified in a SASA that applies to the dental worker in respect of the medicine.
(5) The administration by a dental worker of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the administration —
(a) is on a direction given by a dentist under regulation 15(1); or
(b) is in the circumstances identified in a SASA that applies to the dental worker in respect of the medicine.
(6) The possession by a dental worker of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the possession is for the purpose of administering the medicine in accordance with this regulation.
### Division 5 — Authorisation of first aid providers (vessel)
##### 48. First aid provider (vessel) prescribed for s. 25(1)(a)
First aid provider (vessel) is prescribed as a class of health professional for the purposes of section 25(1)(a).
##### 49. Authorisation of first aid providers (vessel)
livestock export standard means —
(a) *Australian Standards for the Export of Livestock (Version 2.3) 2011* published by the Department of Agriculture, Fisheries and Forestry of the Commonwealth; or
(b) *Marine Orders — Part 43 (Cargo and cargo handling — livestock) 2006* that is in effect under the *Navigation Act 2012* (Commonwealth).
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that a first aid provider (vessel), acting in the lawful practice of their profession, may supply.
(3) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 or 8 poison listed in the Table in respect of a type of vessel is a medicine that a first aid provider (vessel) on that type of vessel, acting in the lawful practice of their profession, may —
| **Type of vessel** | **Medicines** |
| Domestic commercial vessel | A medicine that is a Schedule 4 or 8 poison that is necessary for the vessel to comply with the requirements of the *National Standard for Commercial Vessels* published by the Australian Maritime Safety Authority |
| Foreign vessel | A medicine that is a Schedule 4 or 8 poison that is necessary for the vessel to comply with the *International Medical Guide for Ships*, Third Edition published by the World Health Organisation |
| Racing yacht | A medicine that is a Schedule 4 or 8 poison that is necessary for the yacht to comply with the requirements of the *Racing Rules of Sailing* made by Australian Sailing Ltd |
| Regulated Australian vessel | A medicine that is a Schedule 4 or 8 poison that is necessary for the vessel to comply with the requirements of *Marine Order 11 (Living and working conditions on vessels) 2015* that is in effect under the *Navigation Act 2012* (Commonwealth) |
| Regulated Australian vessel carrying livestock for export | A medicine that is a Schedule 4 poison that is necessary for compliance with a requirement relating to veterinary treatment set out in a livestock export standard |
(4) The administration or supply by a first aid provider (vessel) of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the administration or supply is for the treatment of a person or animal on the vessel.
(5) The possession by a first aid provider (vessel) of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the possession is for the purpose of administering or supplying the medicine in accordance with this regulation.
### Division 6 — Authorisation of medical practitioners
##### 50. Medical practitioner prescribed for s. 25(1)(a)
Medical practitioner is a class of health professional prescribed for the purposes of section 25(1)(a).
##### 51. Authorisation of medical practitioners
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that a medical practitioner, acting in the lawful practice of their profession, may supply.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 or 8 poison is a medicine that a medical practitioner, acting in the lawful practice of their profession, may —
(3) The prescription or supply by a medical practitioner of a medicine that is a Schedule 8 poison is subject to Part 11.
### Division 7 — Authorisation of nurses and midwives
##### 52. Classes of nurse and midwife prescribed for s. 25(1)(a)
(a) nurse practitioner;
(b) registered nurse;
(c) enrolled nurse;
(d) midwife.
##### 53. Authorisation of nurse practitioners
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that a nurse practitioner, acting in the lawful practice of their profession, may supply.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 or 8 poison is a medicine that a nurse practitioner, acting in the lawful practice of their profession, may —
(3) The prescription or supply by a nurse practitioner of a medicine that is a Schedule 8 poison is subject to Part 11.
##### 54. Authorisation of registered nurses
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that a registered nurse, acting in the lawful practice of their profession, may supply.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 poison is a medicine that a registered nurse, acting in the lawful practice of their profession, may —
(3) For the purposes of section 25(1)(b), a medicine that is a Schedule 8 poison is a medicine that a registered nurse, acting in the lawful practice of their profession, may —
(4) The supply by a registered nurse of a medicine that is a Schedule 2, 3 or 4 poison is subject to the condition that the supply is —
(b) in the circumstances identified in a SASA that applies to the registered nurse in respect of the medicine.
(c) when the supply occurs there is no pharmacy within 25 km of the place of supply that is open and accessible by the person to whom the medicine is supplied;
(d) the supply is not for the purposes of acute care or treatment relating to the implementation of a public health programme;
(e) the person to whom the medicine is supplied has consulted with a medical practitioner, in the period of 6 months before the day on which the supply occurs, about the medical condition to which the supply relates;
(5) The administration by a registered nurse of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the administration —
(b) is in the circumstances identified in a SASA that applies to the registered nurse in respect of the medicine.
(6) The possession by a registered nurse of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the possession is for the purpose of administering or supplying the medicine in accordance with this regulation.
[Regulation 54 amended: Gazette 15 Mar 2019 p. 790-1.]
##### 55. Authorisation of enrolled nurses
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that an enrolled nurse, acting in the lawful practice of their profession, may supply.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 poison is a medicine that an enrolled nurse, acting in the lawful practice of their profession, may —
(3) For the purposes of section 25(1)(b), a medicine that is a Schedule 8 poison is a medicine that an enrolled nurse, acting in the lawful practice of their profession, may —
(4) The supply by an enrolled nurse of a medicine that is a Schedule 2, 3 or 4 poison is subject to the condition that the supply is —
(b) in the circumstances identified in a SASA that applies to the enrolled nurse in respect of the medicine.
(c) when the supply occurs there is no pharmacy within 25 km of the place of supply that is open and accessible by the person to whom the medicine is supplied;
(d) the supply is not for the purposes of acute care or treatment relating to the implementation of a public health programme;
(e) the person to whom the medicine is supplied has consulted with a medical practitioner, in the period of 6 months before the day on which the supply occurs, about the medical condition to which the supply relates;
(5) The administration by an enrolled nurse of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the administration —
(b) is in the circumstances identified in a SASA that applies to the enrolled nurse in respect of the medicine.
(6) The possession by an enrolled nurse of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the possession is for the purpose of administering or supplying the medicine in accordance with this regulation.
[Regulation 55 amended: Gazette 15 Mar 2019 p. 791.]
##### 56. Authorisation of midwives
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that a midwife, acting in the lawful practice of their profession, may supply.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 poison is a medicine that a midwife, acting in the lawful practice of their profession, may —
(3) For the purposes of section 25(1)(b), a medicine that is a Schedule 8 poison is a medicine that a midwife, acting in the lawful practice of their profession, may —
(4) The supply by a midwife of a medicine that is a Schedule 2, 3 or 4 poison is subject to the condition that the supply is —
(b) in the circumstances identified in a SASA that applies to the midwife in respect of the medicine.
(c) when the supply occurs there is no pharmacy within 25 km of the place of supply that is open and accessible by the person to whom the medicine is supplied;
(d) the supply is not for the purposes of acute care or treatment relating to the implementation of a public health programme;
(e) the person to whom the medicine is supplied has consulted with a medical practitioner, in the period of 6 months before the day on which the supply occurs, about the medical condition to which the supply relates;
(5) The administration by a midwife of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the administration —
(b) is in the circumstances identified in a SASA that applies to the midwife in respect of the medicine.
(6) The possession by a midwife of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the possession is for the purpose of administering or supplying the medicine in accordance with this regulation.
[Regulation 56 amended: Gazette 15 Mar 2019 p. 792.]
##### 57. Authorisation of endorsed midwives
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that an endorsed midwife, acting in the lawful practice of their profession, may supply.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 or 8 poison is a medicine that an endorsed midwife, acting in the lawful practice of their profession, may —
(3) The prescription or supply by an endorsed midwife of a medicine that is a Schedule 8 poison is subject to Part 11.
(4) The prescription by an endorsed midwife of a medicine that is a Schedule 8 poison is subject to the condition that the prescription is not for the purpose of the administration of the medicine by a person other than the midwife.
(5) The possession by an endorsed midwife of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the possession is for the purpose of administering or supplying the medicine in accordance with this regulation.
(6) This regulation applies in addition to regulation 56.
[Regulation 57 amended: Gazette 19 Nov 2019 p. 4051-2.]
### Division 8 — Authorisation of optometrists
##### 58. Optometrist prescribed for s. 25(1)(a)
Optometrist is a class of health professional prescribed for the purposes of section 25(1)(a).
##### 59. Authorisation of optometrists
Optometry guidelines means the *Optometry guidelines for use of scheduled medicines* published by the Optometry Board of Australia.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that an optometrist, acting in the lawful practice of their profession, may supply.
(3) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 poison is a medicine that an optometrist, acting in the lawful practice of their profession, may —
(4) The supply by an optometrist of a medicine that is a Schedule 2 or 3 poison is subject to the condition that the supply is in accordance with the Optometry guidelines.
(5) The administration by an optometrist of a medicine that is a Schedule 4 poison is subject to the condition that the administration is in accordance with the Optometry guidelines.
(6) The possession by an optometrist of a medicine that is a Schedule 4 poison is subject to the condition that the possession is for the purpose of administering the medicine in accordance with this regulation.
##### 60. Authorisation of endorsed optometrists
Standard for Optometrists means the *Endorsement for Scheduled Medicines Registration Standard* Table 1 approved by the Australian Health Workforce Ministerial Council.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 poison listed in the Standard for Optometrists is a medicine that an endorsed optometrist, acting in the lawful practice of their profession, may —
(3) The administration, prescription or supply by an endorsed optometrist of a medicine listed in the Standard for Optometrists that is a Schedule 4 poison is subject to the condition that the administration, prescription or supply complies with any restrictions or conditions set out in the Standard for Optometrists in respect of the medicine.
(4) The possession by an endorsed optometrist of a medicine listed in the Standard for Optometrists that is a Schedule 4 poison is subject to the condition that the possession is for the purpose of administering or supplying the medicine in accordance with this regulation.
(5) This regulation applies in addition to regulation 59.
### Division 9 — Authorisation of paramedics
##### 61. Paramedic prescribed for s. 25(1)(a)
Paramedic is prescribed as a class of health professional for the purposes of section 25(1)(a).
##### 62. Authorisation of paramedics
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that a paramedic, acting in the lawful practice of their profession, may supply.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 or 8 poison is a medicine that a paramedic, acting in the lawful practice of their profession, may —
(3) The supply by a paramedic of a medicine is subject to the condition that the supply is in the circumstances identified in a SASA that applies to the paramedic in respect of the medicine.
(4) The administration by a paramedic of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the administration —
(b) is in the circumstances identified in a SASA that applies to the paramedic in respect of the medicine.
(5) The possession by a paramedic of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the possession is for the purpose of administering or supplying the medicine in accordance with this regulation.
### Division 9A — Authorisation of medics
[Heading inserted: Gazette 13 Nov 2018 p. 4431.]
##### 62A. Medic prescribed for s. 25(1)(a)
Medic is prescribed as a class of health professional for the purposes of section 25(1)(a).
[Regulation 62A inserted: Gazette 13 Nov 2018 p. 4431.]
##### 62B. Authorisation of medics
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that a medic, acting in the lawful practice of their profession, may supply.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 or 8 poison is a medicine that a medic, acting in the lawful practice of their profession, may —
(3) The supply by a medic of a medicine is subject to the condition that the supply is in the circumstances identified in a SASA that applies to the medic in respect of the medicine.
(4) The administration by a medic of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the administration —
(b) is in the circumstances identified in a SASA that applies to the medic in respect of the medicine.
(5) The possession by a medic of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the possession is for the purpose of administering or supplying the medicine in accordance with this regulation.
[Regulation 62B inserted: Gazette 13 Nov 2018 p. 4431.]
### Division 10 — Authorisation of pharmacists
##### 63. Pharmacist prescribed for s. 25(1)(a)
Pharmacist is prescribed as a class of health professional for the purposes of section 25(1)(a).
##### 64. Authorisation of pharmacists
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that a pharmacist, acting in the lawful practice of their profession, may supply.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 or 8 poison is a medicine that a pharmacist, acting in the lawful practice of their profession, may —
(b) dispense; or
(c) possess; or
(3) The administration by a pharmacist of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the administration is in the circumstances identified in a SASA that applies to the pharmacist in respect of the medicine.
(4) The dispensing by a pharmacist of a medicine that is a Schedule 4 or 8 poison is subject to the condition that —
(a) the medicine is dispensed to a person (the patient) and —
(i) the medicine was prescribed for the patient by a prescriber; and
(ii) the pharmacist reasonably believes that the patient will use the medicine in accordance with the instructions of the prescriber;
or
(b) the medicine is dispensed to a person (the agent) and —
(i) the medicine is dispensed to the agent for the purpose of it being administered or supplied to another person or to an animal (the patient); and
(ii) the medicine was prescribed for the patient by a prescriber; and
(iii) the pharmacist reasonably believes that the medicine will be administered or supplied to the patient in accordance with the instructions of the prescriber.
(5) The supply by a pharmacist of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the supply —
(a) is in the circumstances identified in a SASA that applies to the pharmacist in respect of the medicine; or
(b) is to an authorised health professional in accordance with regulation 32.
### Division 11 — Authorisation of podiatrists
##### 65. Podiatrist prescribed for s. 25(1)(a)
Podiatrist is a class of health professional prescribed for the purposes of section 25(1)(a).
##### 66. Authorisation of podiatrists
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 2 or 3 poison is a medicine that a podiatrist, acting in the lawful practice of their profession, may supply.
(2) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 poison is a medicine that a podiatrist, acting in the lawful practice of their profession, may —
(3) The supply by a podiatrist of a medicine that is a Schedule 2, 3 or 4 poison is subject to the condition that the supply is in the circumstances identified in a SASA that applies to the podiatrist in respect of the medicine.
(4) The administration by a podiatrist of a medicine that is a Schedule 4 poison is subject to the condition that the administration —
(b) is in the circumstances identified in a SASA that applies to the podiatrist in respect of the medicine.
(5) The possession by a podiatrist of a medicine that is a Schedule 4 poison is subject to the condition that the possession is for the purpose of administering or supplying the medicine in accordance with this regulation.
##### 67. Authorisation of endorsed podiatrists
Medicines List means the *National Podiatry Scheduled Medicines List* that is Appendix B to the *Guidelines for Endorsement for Scheduled Medicines* issued by the Podiatry Board of Australia.
(2) For the purposes of section 25(1)(b), a medicine listed in the Medicines List is a medicine that an endorsed podiatrist, acting in the lawful practice of their profession, may —
(3) The administration, prescription or supply by an endorsed podiatrist of a medicine listed in the Medicines List is subject to the condition that the administration, prescription or supply complies with any conditions or restrictions set out in the Medicines List in respect of the medicine.
(4) The possession by an endorsed podiatrist of a medicine listed in the Medicines List that is a Schedule 4 or 8 poison is subject to the condition that the possession is for the purpose of administering or supplying the medicine in accordance with this regulation.
(5) This regulation applies in addition to regulation 66.
### Division 12 — Authorisation of veterinary professionals
##### 68. Classes of veterinary professional prescribed for s. 25(1)(a)
(a) veterinarian;
(b) veterinary nurse;
(c) VPB‑authorised person.
[Regulation 68 amended: SL 2022/93 r. 5; SL 2025/212 r. 6.]
##### 69. Authorisation of veterinarians
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 or 8 poison is a medicine that a veterinarian, acting in the lawful practice of their profession, may —
(2) The prescription by a veterinarian of a medicine that is a Schedule 8 poison is subject to the condition that the prescription does not provide for the poison to be dispensed on more than one occasion.
[Regulation 69 amended: SL 2022/93 r. 5.]
##### 70. Authorisation of veterinary nurses
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 or 8 poison is a medicine that a veterinary nurse, acting in the lawful practice of their profession, may —
(2) The administration by a veterinary nurse of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the administration is on the direct instruction of a veterinarian to administer the medicine to a particular animal.
(3) The possession by a veterinary nurse of a medicine that is a Schedule 4 or 8 poison is subject to the condition that the possession is for the purpose of administering the medicine in accordance with this regulation.
[Regulation 70 amended: SL 2022/93 r. 5.]
##### 70A. Authorisation of VPB‑authorised persons
(1) For the purposes of section 25(1)(b), a medicine that is a Schedule 4 poison is a medicine that a VPB‑authorised person, acting in the lawful practice of their profession, may —
(2) The possession by a VPB‑authorised person of a medicine that is a Schedule 4 poison is subject to the condition that the possession is for the purpose of administering the medicine.
(3) The possession by a VPB‑authorised person of a medicine that is a Schedule 4 poison is subject to the condition that the medicine was supplied by a veterinarian.
[Regulation 70A inserted: SL 2025/212 r. 7.]
## Part 8 — Licences and permits
##### 71. Term used: specified
specified, in relation to a licence or permit, means specified in the licence or permit.
##### 72. Purposes for licence or permit for Schedule 9 poison
(1) For the purposes of section 35(a), the following are prescribed as purposes for which the manufacture or supply of a Schedule 9 poison may be authorised by a licence —
(a) chemical analysis;
(b) treatment or anaesthesia of exotic animals;
(c) training animals to detect Schedule 9 poisons.
(2) For the purposes of section 37, the following are prescribed as purposes for which the use of a Schedule 9 poison may be authorised by a permit —
(a) chemical analysis;
(b) treatment or anaesthesia of exotic animals;
(c) training animals to detect Schedule 9 poisons.
##### 73. Information to be recorded in register for licences and permits
For the purposes of section 75(3), the information that must be recorded in the register for each current licence or permit is the following —
(a) the name of the licensee or permit holder;
(b) contact details for the licensee or permit holder including address, telephone numbers and any email address;
(c) the type of licence or permit;
(d) details of any matters that are specified in the licence or permit;
(e) the dates of grant and expiry of the licence or permit;
(f) if the licence or permit has been suspended — the period of the suspension.
### Division 2 — Licences
##### 74. Types of licence
permitted purpose, in relation to a Schedule 9 poison, means a purpose referred to in section 35(a) or regulation 72(1).
(2) The types of licences that may be granted under the Act and the activities that may be authorised by each type of licence are set out in the Table.
| **Item** | **Type of licence** | **Activities that may be authorised by licence** |
| 1. | Indent licence | To supply specified poisons from premises other than the licensee’s premises |
| 2. | Schedule 2 retail licence | To supply by retail sale specified medicines that are Schedule 2 poisons from specified premises |
| 3. | Schedule 7 retail licence | To supply by retail sale specified Schedule 7 poisons from specified premises |
| 4. | Schedule 9 licence | To manufacture or supply Schedule 9 poisons for a specified permitted purpose at or from specified premises |
| 5. | Wholesaler’s/ manufacturer’s licence | To manufacture and supply by wholesale specified poisons at or from specified premises |
##### 75. Condition on Schedule 7 retail licence: records to be kept
(1) A Schedule 7 retail licence is subject to the condition that the licensee must comply with subregulations (2) and (3).
(2) A record of the retail sale of a Schedule 7 poison must be made in accordance with the current Poisons Standard Part 2 Division 6.
(3) A record of the retail sale of a Schedule 7 poison must —
(a) be kept for a period of 5 years commencing on the day the poison is supplied; and
(b) be produced for inspection on the request of an investigator.
[Regulation 75 amended: SL 2023/3 r. 5.]
##### 76. Condition on wholesaler’s/manufacturer’s licence: responsible person
responsible person, in relation to a wholesaler’s/manufacturer’s licence, means —
(a) the person specified as responsible for supervision of activities carried out under the licence; or
(b) a person authorised for the licence under subregulation (3).
(2) A wholesaler’s/manufacturer’s licence is subject to the condition that any manufacture or supply of a poison under the licence must be carried out by or under the direction of a responsible person.
(3) If a person specified as responsible for supervision of activities carried out under a wholesaler’s/manufacturer’s licence is no longer able to supervise those activities, the CEO may, by written notice, authorise another person to be the responsible person for the licence.
##### 77. Condition on wholesaler’s/manufacturer’s licence: supply of Schedule 4 or 8 poison
A wholesaler’s/manufacturer’s licence is subject to the condition that any supply of a Schedule 4 or 8 poison is only to a person —
(a) who is —
(i) authorised by a professional authority or an appropriate licence to manufacture or supply the poison; or
(ii) the holder of an appropriate permit that authorises the person to be in possession of the poison;
and
(b) who has provided the licensee with a written request specifying the quantity, strength and form of the medicine that is to be supplied.
##### 78. Condition on wholesaler’s/manufacturer’s licence: records to be kept for Schedule 2, 3, 4 or 7 poisons
(1) A wholesaler’s/manufacturer’s licence that relates to the manufacture or supply of a Schedule 2, 3 or 4 poison is subject to the condition that the licensee must comply with subregulations (3), (5) and (6).
(2) A wholesaler’s/manufacturer’s licence that relates to the manufacture or supply of a Schedule 7 poison is subject to the condition that the licensee must comply with subregulations (4) to (6).
(3) A record of the supply of a medicine that is a Schedule 2, 3 or 4 poison must —
(a) be made in an approved form on the day the medicine is supplied; and
(b) include the following details —
(i) the day on which the medicine is supplied;
(ii) the quantity, strength and form of the medicine supplied;
(iii) the name and address of the person to whom the medicine is supplied;
(iv) the reference number on the invoice or other document evidencing the supply.
(4) A record of the supply of a Schedule 7 poison must be made in accordance with the current Poisons Standard Part 2 Division 6.
(5) The record of the supply of a poison must —
(a) be kept —
(i) in the case of a medicine that is a Schedule 2, 3 or 4 poison — for a period of 2 years commencing on the day the medicine is supplied; and
(ii) in the case of a Schedule 7 poison — for a period of 5 years commencing on the day the poison is supplied;
and
(b) be produced for inspection on the request of an investigator.
(6) Particulars of any details included in the record of the supply of a poison must, on the written request of the CEO, be provided to the CEO as follows —
(a) if the request relates to details recorded in the period of 2 months before the request — within 7 days of the request;
(b) otherwise — within 28 days of the request.
[Regulation 78 amended: SL 2023/3 r. 6.]
### Division 3 — Permits
##### 79. Types of permit
permitted purpose, in relation to a Schedule 9 poison, means —
(a) a purpose referred to in section 37; or
(b) a purpose referred to in regulation 72(2);
public sector agency means an agency as defined in the *Public Sector Management Act 1994* section 3(1).
(2) The types of permits that may be granted under the Act and the uses that may be authorised by each type of permit are set out in the Table.
| **Item** | **Type of permit** | **Uses that may be authorised by permit** |
| 1. | Health service permit | To use specified medicines in providing health services at specified premises |
| 2. | Health service permit — Department/ hospital | To use specified medicines in providing health services on behalf of the Department or at specified public hospitals including supply of the medicines in connection with providing the health services |
| 3. | Health service permit — Public sector agency | To use specified medicines in providing health services on behalf of a specified public sector agency |
| 4. | Government permit | To use specified poisons for the purpose of carrying out the activities of a specified public sector agency |
| 5. | Industrial permit | To use a specified poison in a specified business |
| 6. | Pharmaceutical samples permit | To carry and supply pharmaceutical samples of medicines that are Schedule 2, 3 or 4 poisons as a representative of a specified manufacturer or wholesale supplier |
| 7. | Research/ Education permit | To use specified poisons for the purpose of education or research on behalf of a specified school, university, government department or research organisation |
| 8. | Schedule 9 permit | To use specified Schedule 9 poisons for specified permitted purposes |
| 9. | Stockfeed manufacture permit | To use specified medicines in the manufacture of stockfeed mixes and the supply of stockfeed mixes containing those medicines |
| 10. | Veterinary practice permit | To use medicines in providing veterinary services |
##### 80. Condition on stockfeed manufacture permit: stockfeed mix containing antibiotic or sulphonamide
(1) A stockfeed manufacture permit is subject to the condition that the permit holder must comply with subregulations (2) and (3).
(2) Any supply by retail of a stockfeed mix containing an antibiotic or sulphonamide must be on a written order for the stockfeed mix that —
(a) is signed in ink by a veterinarian; and
(b) is in respect of the supply of the stockfeed mix on a single occasion.
(3) The written order —
(a) must be kept by the permit holder for at least 2 years from the day the stockfeed mix is supplied; and
(b) must be produced for inspection on the request of an investigator.
[Regulation 80 amended: SL 2022/93 r. 5; SL 2024/265 r. 14.]
##### 81. Conditions on pharmaceutical samples permit
(1) A pharmaceutical samples permit is subject to the condition that the permit holder must not supply a pharmaceutical sample of a medicine to a person unless —
(a) the person is an authorised health professional who is authorised to administer, possess, prescribe, supply or use the medicine; and
(b) the person has given the permit holder a written request for the supply of the sample that is signed by the person.
(2) A pharmaceutical samples permit is subject to the condition that the permit holder must comply with the following requirements in relation to the transport and storage of pharmaceutical samples —
(a) the samples must be stored at the specified premises except when the permit holder is carrying them in a vehicle in the course of the permit holder’s business;
(b) the samples must be stored at the specified premises in a locked cabinet or refrigerator;
(c) not more than 100 samples of any single medicine or samples of not more than 5 different medicines may be stored at the specified premises at any one time;
(d) not more than 25 samples of any single medicine or samples of not more than 5 different medicines may be carried in a vehicle at any one time.
(3) The CEO may, by written notice, vary the condition referred to in subregulation (2) to authorise the transport or storage of pharmaceutical samples in another specified manner.
(4) A pharmaceutical samples permit is subject to the condition that the permit holder must —
(a) make a written record of every pharmaceutical sample received or supplied by the permit holder; and
(b) keep the record together with consignment notes, invoices, advice notes and request forms relating to the record for a period of at least 2 years commencing on the day the sample is received or supplied; and
(c) on the written request of the CEO submit the record and supporting documentation to the CEO.
## Part 9 — Requirements relating to manufacture, supply, handling, storage, transport and disposal of poisons
### Division 1 — General requirements for containers and labels
##### 82. Container and its labels to comply with current Poisons Standard
A poison must not be stored, supplied or transported unless —
(a) the immediate container in which the poison is stored, supplied or transported complies with the current Poisons Standard Part 2 or its use is authorised under regulation 84; and
(b) the container bears or has securely fixed to it a label which complies with the current Poisons Standard Part 2 or the use of which is authorised under regulation 84; and
(c) the container and the label comply with any other requirements in this Division.
[Regulation 82 amended: SL 2023/3 r. 7.]
##### 83. Use of certain containers prohibited
A paper or plastic bag or envelope or a cardboard box must not be used as a container for a medicine or a Schedule 9 poison unless —
(a) within the container, the medicine or poison is individually sealed in measured amounts in a form commonly described as strip packaging; or
(b) the use of the container is authorised under regulation 84.
##### 84. Authorisation of container or label
Appendix K poison means a poison listed in the current Poisons Standard Appendix K.
(2) The label for a medicine containing an Appendix K poison for human internal use that is not labelled with a sedation warning as required under the current Poisons Standard Part 2 is authorised if —
(a) the medicine is stored, supplied or transported by a person who is the holder of a licence that authorises the manufacture or supply of the medicine; or
(b) the medicine is supplied for the treatment of a patient in a hospital.
(3) The label for a medicine that is a Schedule 4 or 8 poison is authorised if —
(a) the medicine is supplied by an authorised health professional; and
(b) the immediate container in which the medicine is supplied bears, or has securely fixed to it, a label which complies with the current Poisons Standard Appendix L.
(4) The CEO may authorise the use of a container which does not comply with regulation 82(a) or 83(a) if the CEO is satisfied that, having regard to the nature of the poison and the purpose for which it is to be used, the use of the container is unlikely to adversely affect public safety.
(5) The CEO may authorise the use of a label which does not comply with regulation 82(b) if the CEO is satisfied that, having regard to the nature of the poison and the purpose for which it is to be used, the use of the label is unlikely to adversely affect public safety.
(6) An authorisation under subregulation (4) or (5) —
[Regulation 84 amended: SL 2023/3 r. 7.]
##### 85. Suspending or prohibiting use of container or label
non‑compliant container or label means —
(a) a container that does not comply with regulation 82(a); or
(b) a label that does not comply with regulation 82(b).
(2) The CEO may, by notice given to a person, direct the person to immediately suspend or stop the use of a container or label if the CEO is satisfied that —
(a) the container or label is a non‑compliant container or label; and
(b) the use of the container or label may adversely affect public safety.
(3) The notice —
(4) A person must comply with a notice given to the person under subregulation (2).
### Division 2 — Requirements for medicine that is Schedule 2 poison
##### 86. Storage of medicine that is Schedule 2 poison